ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit

ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit

Source: 
EP Vantage
snippet: 

A similar benefit suggests a class effect with the SGLT2s in heart failure, leaving Lilly and Boehringer playing catch-up to Astra.